| Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth. | ovarian, |
| [Significance of her2 oncogene expression in primary nasopharyngeal carcinoma]. | nasopharyngeal,laryngeal, |
| C-erbB-2 oncoprotein content in colorectal cancer and in surrounding mucosa: relationship with clinicopathologic parameters and prognostic significance. | colorectal, |
| Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma. | lung, |
| The role of HER-2 oncoprotein in drug-sensitivity in breast cancer (review). | breast, |
| Serum and tissue c-erb B2, bcl-2, and mutant p53 oncoprotein levels in nasopharyngeal cancer. | nasopharyngeal,laryngeal, |
| Her-2/neu oncogene expression in Puerto Rican females with breast cancer. | breast, |
| Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer. | prostate, |
| Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer. | prostate, |
| Study of differential polymerase chain reaction of C-erbB-2 oncogene amplification in gastric cancer. | gastric, |
| C-erbB-2 oncoprotein in gastric carcinoma: correlation with clinical stage and prognosis. | gastric, |
| Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma | laryngeal, |
| Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma. | laryngeal, |
| Data suggest that amplification of Her-2/neu appears to be mainly involved in initiation of breast oncogenesis and that its role in progression of breast cancers is uncertain. | breast, |
| Her-2/neu oncogene amplification in clinically localised prostate cancer. | prostate, |
| Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes. | breast, |
| Comparison of HER-2/neu oncogene amplification detected by fluorescence in situ hybridization in lobular and ductal breast cancer. | breast, |
| Reliability of the tissue microarray based FISH for evaluation of the HER-2 oncogene in breast carcinoma. | breast, |
| Independent prognostic significance of HER-2 oncoprotein expression in pN0 prostate cancer undergoing curative radiotherapy. | prostate, |
| [HER-2/neu oncogene in the selection of treatment for breast cancer and as a target of immunotherapy]. | breast, |